Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase I/II Study of Nivolumab and Vorolanib in Patients with Refractory Thoracic Tumors Whisenant, J., Beckermann, K., Borghaei, H., Owonikoko, T., Patel, J., Berry, L., Shyr, Y., Harrow, K., Liang, C., Holzhausen, A., Selvaggi, G., Wakelee, H., Horn, L. ELSEVIER SCIENCE INC. 2019: S445–S446
View details for Web of Science ID 000492162202249